Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS
Verona Pharma plc (VRNA): A Bull Case Theory [Yahoo! Finance]
Verona Pharma plc (NASDAQ: VRNA) was given a new $83.00 price target on by analysts at Roth Capital.
Verona Pharma plc (NASDAQ: VRNA) had its price target raised by analysts at Wells Fargo & Company from $74.00 to $93.00. They now have an "overweight" rating on the stock.
Verona Pharma plc (NASDAQ: VRNA) had its price target raised by analysts at HC Wainwright from $60.00 to $75.00. They now have a "buy" rating on the stock.